Chebulagic acid targets FBXO38 to enhance natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma

Key Points

• Chebulagic acid enhances natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma.
• The expression of FBXO38 is a significant factor in this immune response.
• Assessment of immune markers demonstrates improved efficacy against tumors when treated with chebulagic acid.
• Further clinical research is warranted to evaluate the therapeutic potential of chebulagic acid in cancer treatment.